Nexviadyme

Active substance avalglucosidase alfa
Holder Sanofi Belgium
Status Closed
Indication treatment of adult Pompe disease patients who have participated and exit the clinical studies COMET (EFC14028) or NEO-EXT (LTS13769)
Public documents Approbation
  Information for the patient
  Informed consent
Last update 05/10/2023

 

Last updated on 13/02/2024